首页 | 本学科首页   官方微博 | 高级检索  
     

气管炎贴膏治疗慢性支气管炎的临床研究
引用本文:霍国荣,马丽乾,黄晨辉,刘忠昌,郑莉莉,吴斌. 气管炎贴膏治疗慢性支气管炎的临床研究[J]. 中国中西医结合杂志, 2001, 21(11): 816-818
作者姓名:霍国荣  马丽乾  黄晨辉  刘忠昌  郑莉莉  吴斌
作者单位:1. 甘肃省兰州市第二人民医院,
2. 甘肃省兰州市第一人民医院
基金项目:甘肃省兰州市科委科研基金资助课题(No.98-1-67)
摘    要:目的:探讨气管炎贴膏治疗慢性支气管炎的临床疗效及作用机制。方法:设立治疗、对照两组,治疗组(59例)在背部胸椎1-6两侧(定喘、大杼、风门、肺俞、心俞)用气管炎贴膏(由麻黄、杏仁、半夏、地龙、白芥子组成)贴敷,对照组(25例)用斯奇康注射液肌肉注射,两组均连续用药20次,用药前后记录患者临床症状,拍胸部X线片,测定免疫球蛋白(IgG、IgA及IgM)和T细胞亚群(CD3、CD4及CD8)水平,并随访0.5、1年。结果:治疗组临床总有效率达93.2%,胸部X线片改善总有效率为40.7%;对照组分别为80.0%和20.0%。停药后0.5、1年的临床总有效率,治疗组分别为91.5%、89.8%,对照组分别为80.0%、76.0%。总有效率治疗组均明显优于对照组(P<0.05)。IgG和CD8的变化治疗组均优于对照组(P<0.05)。结论:气管炎贴 膏能调节免疫功能,是一种疗效高、远期疗效好的透皮吸收剂。

关 键 词:气管炎贴膏  慢性支气管炎  免疫球蛋白  T细胞亚群
修稿时间:2001-03-16

Clinical Study on Treatment of Chronic Bronchitis by Tracheitis Plaster
HUO Guo rong,MA Li qian,HUANG Chen hui. Clinical Study on Treatment of Chronic Bronchitis by Tracheitis Plaster[J]. Chinese journal of integrated traditional and Western medicine, 2001, 21(11): 816-818
Authors:HUO Guo rong  MA Li qian  HUANG Chen hui
Abstract:Objective: To study the clinical effect and mechanism of Tracheitis Plaster (TP) in treating chronic bronchitis. Methods: TP is consisted of ephedra, almond, pinellia tuber, earthworm and white mustard seed. Patients were randomly divided into two groups, 59 patients in the treated group were treated with TP sticking on acupoints Dingchuan, Dashu, Fengmen, Feishu and Xinshu at back along both sides of thoracic vertebrae 1-6 and the 25 patients in the control group were treated with intramuscular injection of Siqikang. The times of treatment for both groups were 20. Clinical symptoms, X ray chest film, level of immunoglobulin and T lymphocyte subsets were recorded before and after treatment, and follow up were carried out 0.5-1 year later. Results: The clinical total effective rate was 93.2% and the X ray improvement rate was 40.7% in the treated group, while in the control group, 80 0% and 20 0% respectively. Half and 1 year follow up studies showed the total effective rate in the treated group was 91.5% and 89.8% respectively, which was significantly higher than that in the control group (80 0% and 76 0%) respectively (P<0 05). The improvement in levels of IgG and CD 8 in the treated group was also superior to those in the control group (P<0 05). Conclusion: TP is a highly effective transcutaneous absorbent with promising long term effect, it could regulate the immune function.
Keywords:Tracheitis Plaster   chronic bronchitis   immunoglobulin   T lymphocyte subset  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号